On the public citation graph
Challenges in the Design of Multitarget Drugs Against Multifactorial Pathologies: A New Life for Medicinal Chemistry?
0 signed · 46 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/9780470524961.ch1openalex-snapshot
Discovery and Development of Sunitinib (SU11248): A Multitarget Tyrosine Kinase Inhibitor of Tumor Growth, Survival, and Angiogenesis
inferredcites →https://doi.org/10.1002/9780470524961.ch18openalex-snapshot
Fragment‐Based Drug Discovery of Kinase Inhibitors
inferredcites →https://doi.org/10.1002/path.4052openalex-snapshot
Differential drug class‐specific metastatic effects following treatment with a panel of angiogenesis inhibitors
inferredcites →https://doi.org/10.1016/j.ccr.2009.01.021openalex-snapshot
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
inferredcites →https://doi.org/10.1016/j.ccr.2009.01.027openalex-snapshot
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
inferredcites →https://doi.org/10.1016/j.copbio.2010.05.004openalex-snapshot
Biochemical network-based drug-target prediction
inferredcites →https://doi.org/10.1016/j.drudis.2011.08.002openalex-snapshot
The role of fragment-based and computational methods in polypharmacology
inferredcites →https://doi.org/10.1016/s0065-7743(08)00017-1openalex-snapshot
Recent Advances in the Discovery of Hybrid Antibacterial Agents
inferredcites →https://doi.org/10.1021/jm201649sopenalex-snapshot
Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
inferredcites →https://doi.org/10.1021/jm300338mopenalex-snapshot
Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors
inferredcites →https://doi.org/10.1038/nm.2537openalex-snapshot
Tumor angiogenesis: molecular pathways and therapeutic targets
inferredcites →https://doi.org/10.1038/nrc3261openalex-snapshot
Intra-tumour heterogeneity: a looking glass for cancer?
inferredcites →https://doi.org/10.1038/nrd2155openalex-snapshot
Why is cancer drug discovery so difficult?
inferredcites →https://doi.org/10.1038/nrd3681openalex-snapshot
Diagnosing the decline in pharmaceutical R&D efficiency
inferredcites →https://doi.org/10.1039/9781849733557-00079openalex-snapshot
The Learning and Evolution of Medicinal Chemistry against Kinase Targets
inferredcites →https://doi.org/10.1371/journal.pcbi.1000550openalex-snapshot
Structure of Protein Interaction Networks and Their Implications on Drug Design
inferredcites →https://doi.org/10.2174/092986712801215883openalex-snapshot
Designed Multiple Ligands: Basic Research vs Clinical Outcomes
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/med.21505openalex-snapshot
Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer
inferred← citeshttps://doi.org/10.1002/minf.201700073openalex-snapshot
Ligand‐based Modeling for the Prediction of Pharmacophore Features for Multi‐targeted Inhibition of the Arachidonic Acid Cascade
inferred← citeshttps://doi.org/10.1007/978-1-4939-7404-7_19openalex-snapshot
Computational Modeling of Multi-target-Directed Inhibitors Against Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_2openalex-snapshot
Strategies of Polypharmacology
inferred← citeshttps://doi.org/10.1007/978-94-024-1045-7_8openalex-snapshot
Natural Compounds Are Smart Players in Context to Anticancer Potential of Receptor Tyrosine Kinases: An In Silico and In Vitro Advancement
inferred← citeshttps://doi.org/10.1007/s12032-015-0678-8openalex-snapshot
Screening of multi-targeted natural compounds for receptor tyrosine kinases inhibitors and biological evaluation on cancer cell lines, in silico and in vitro
inferred← citeshttps://doi.org/10.1016/j.bcp.2025.117420openalex-snapshot
Zaltoprofen and its novel analogues exhibit dual targeting of COX-2 and PPAR-γ, providing a strategy to alleviate lipopolysaccharide – induced acute lung injury
inferred← citeshttps://doi.org/10.1016/j.bmc.2013.09.023openalex-snapshot
The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase
inferred← citeshttps://doi.org/10.1016/j.bmc.2016.10.006openalex-snapshot
Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ejmech.2015.03.035openalex-snapshot
Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112742openalex-snapshot
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112904openalex-snapshot
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors
inferred← citeshttps://doi.org/10.1016/j.molstruc.2022.134116openalex-snapshot
A molecular hybridization approach for the design of selective aldose reductase (ALR2) inhibitors and exploration of their activities against protein tyrosine phosphatase 1B (PTP1B)
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00045openalex-snapshot
Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial Dysfunction
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00726openalex-snapshot
Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.4c00843openalex-snapshot
Semisynthesis of Glycosmis pentaphylla Alkaloid Derivatives: Pyranoacridone-Hydroxamic Acid Cytotoxic Conjugates with HDAC and Topoisomerase II α Dual Inhibitory Activity
inferred← citeshttps://doi.org/10.1039/c4ra05508jopenalex-snapshot
Design, synthesis and biological evaluation of 4′-demethyl-4-deoxypodophyllotoxin derivatives as novel tubulin and histone deacetylase dual inhibitors
inferred← citeshttps://doi.org/10.1080/14756366.2024.2366236openalex-snapshot
Development of a multi-targeted chemotherapeutic approach based on G-quadruplex stabilisation and carbonic anhydrase inhibition
inferred← citeshttps://doi.org/10.1186/1758-2946-5-33openalex-snapshot
Inferring multi-target QSAR models with taxonomy-based multi-task learning
inferred← citeshttps://doi.org/10.1517/17460441.2016.1146250openalex-snapshot
Use of machine learning approaches for novel drug discovery
inferred← citeshttps://doi.org/10.17863/cam.38293openalex-snapshot
Computer-Aided Design of Ligands at Multiple Protein Targets for Multifactorial Diseases
inferred← citeshttps://doi.org/10.2174/1871530319666181217123357openalex-snapshot
Multi-Target Drugs Against Metabolic Disorders
inferred← citeshttps://doi.org/10.3390/md19100535openalex-snapshot
Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes
inferred← citeshttps://doi.org/10.4155/fmc-2017-0050openalex-snapshot
Multiple Target-Centric Strategy to Tame Inflammation
inferred← citeshttps://doi.org/10.4155/fmc.14.112openalex-snapshot
Multitarget Inhibitors Derived from Crosstalk Mechanism Involving VEGFR2
inferred← citeshttps://doi.org/10.9734/ijpr/2024/v13i6334openalex-snapshot
Antimicrobial Resistance and Its Societal Implications: A Comprehensive Review
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.